Crossmark

Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma

Crossref DOI link: https://doi.org/10.1007/s00280-015-2919-0

Published Online: 2015-12-10

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cereda, S.

Milella, M.

Cordio, S.

Leone, F.

Aprile, G.

Galiano, A.

Mosconi, S.

Vasile, E.

Santini, D.

Belli, C.

Auriemma, A.

Novarino, A.

Vaccaro, V.

Martines, C.

Marino, D.

Lutrino, S. E.

Palazzo, V.

Reinach, B.

Aldrighetti, L.

Reni, M.
License Information

Text and Data Mining valid from 2015-12-10